4.7 Article

Developing machine learning algorithms for dynamic estimation of progression during active surveillance for prostate cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Urology & Nephrology

Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy

Peter-Paul M. Willemse et al.

Summary: This qualitative systematic review explores the criteria for recruitment, monitoring, and reclassification in active surveillance protocols for localized prostate cancer. The study found that a minority of protocols included the use of MRI, and it recommends improvements in biopsy strategies for protocols without mandatory MRI use.

EUROPEAN UROLOGY (2022)

Article Oncology

A machine learning approach to predict progression on active surveillance for prostate cancer

Madhur Nayan et al.

Summary: Machine learning methods significantly outperformed traditional statistical methods in predicting progression on active surveillance for prostate cancer. The study found that machine learning models had higher predictive accuracy compared to the traditional logistic regression model.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

Article Urology & Nephrology

Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance

Anirudh Tomer et al.

Summary: The study developed a model and methodology to predict the risk of Gleason upgrading in patients with prostate cancer on active surveillance, providing risk-based personalised biopsy decisions and potentially reducing unnecessary biopsies. The validated model and schedules are available through a web-application for shared decision-making on biopsy schedules.

BJU INTERNATIONAL (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance

Iztok Caglic et al.

Summary: The study evaluated the predictive value of the PRECISE scoring system in prostate cancer patients on active surveillance, showing good overall performance with high sensitivity, specificity, and negative predictive value. Prostate-specific antigen density, Likert lesion score, and index lesion size were significant baseline predictors of disease progression.

EUROPEAN RADIOLOGY (2021)

Article Oncology

Trends in the use of active surveillance and treatments in Medicare beneficiaries diagnosed with localized prostate cancer

Yu Liu et al.

Summary: The study found a significant increase in the use of active surveillance among men diagnosed with localized prostate cancer and a lower likelihood of non-Hispanic black men with a Gleason score of 6 or below to receive active surveillance. Patients with a Gleason score of 7 or above tended to undergo intensity-modulated radiation therapy or prostatectomy, especially among those aged 75 years and older.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)

Review Health Care Sciences & Services

Artificial Intelligence Techniques That May Be Applied to Primary Care Data to Facilitate Earlier Diagnosis of Cancer: Systematic Review

Owain T. Jones et al.

Summary: This study aimed to systematically review AI techniques that may facilitate earlier diagnosis of cancer. Although AI techniques have been applied to EHR-type data to facilitate early diagnosis of cancer, their use in primary care settings is still at an early stage of maturity.

JOURNAL OF MEDICAL INTERNET RESEARCH (2021)

Review Genetics & Heredity

Deep learning in cancer diagnosis, prognosis and treatment selection

Khoa A. Tran et al.

Summary: Deep learning, a subdiscipline of artificial intelligence, is increasingly being applied in healthcare, particularly in cancer research. While promising results have been achieved, there are still many challenges in applying deep learning to oncology, including the need for more explainable deep learning models.

GENOME MEDICINE (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Surveillance Strategy after Complete Ablation of Initial Recurrent Hepatocellular Carcinoma: A Risk-Based Machine Learning Study

Qi-Feng Chen et al.

Summary: The study investigated surveillance strategies for initial recurrent hepatocellular carcinoma (irHCC) after ablation, finding that the surveillance regime primarily focused on the first year after treatment, especially the initial 6 months. The proposed 6-visit surveillance strategy significantly reduced the delay in detection compared to the control 7-visit approach.

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2021)

Article Oncology

Evaluation of disease staging and chemotherapeutic response in non-small cell lung cancer from patient tumor-derived metabolomic data

Hunter A. Miller et al.

Summary: This study explores predictive models for staging and chemotherapy response in non-small cell lung cancer based on metabolomic analysis of patient-derived core biopsies. Machine learning techniques were applied to differentiate between different disease statuses and treatment responses with high accuracy. The results demonstrate the potential for comprehensive evaluation of patient-specific metabolic profiles to guide clinical decision-making.

LUNG CANCER (2021)

Article Engineering, Biomedical

Dynamic-DeepHit: A Deep Learning Approach for Dynamic Survival Analysis With Competing Risks Based on Longitudinal Data

Changhee Lee et al.

IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2020)

Article Andrology

Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030

Qiliang Cai et al.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2020)

Article Mathematical & Computational Biology

On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data

Hajime Uno et al.

STATISTICS IN MEDICINE (2011)